DOI: http://dx.doi.org/10.18203/2349-3933.ijam20200589

Study of effect of glycemic control on haemoglobin levels in patients with type 2 diabetes mellitus

Aishhwarrya Umeshchandara G., Ravi K.

Abstract


Background: Anemia is more frequent and severe in diabetics compared to non-diabetic patients. Chronic anemia results in tissue hypoxia, which is known to play a key role in diabetes-associated organ damage. Hence it is important to diagnose and correct anemia in diabetic patients. This study was done to elucidate the effect of glycemic control on haemoglobin levels in patients with type 2 Diabetes mellitus.

Methods: The present study is an observational, cross sectional study conducted between November 2017 to May 2019 carried out in hospitals attached to Bangalore Medical college and Research Institute. A sample of 60 patients with Diabetes mellitus were included, out of which 28 were female and 32 were male patients.

Results: Study was conducted on 60 patients, the age distribution was between 29yrs to 88yrs with mean age was 56±11yrs. Out of 60 patients 23 patients had anemia. There was slight positive correlation between haemoglobin percentage and HbA1c. But this was not statistically significant.

Conclusions: The study concludes that Glycemic control was not found to influence the Haemoglobin levels in patients with Type 2 diabetes mellitus in a significant manner. In subjects with anemia, multiple other issues need to be addressed for improvement in haematocrit value and prevention of complications of diabetes apart from glycemic control.


Keywords


Anemia, Glycemic control, Type 2 diabetes mellitus

Full Text:

PDF

References


Ramachandran A, Snehalatha C, Shetty AS, Nanditha A. Trends in prevalence of diabetes in Asian countries. World J Diabetes. 2012 Jun 15;3(6):110-7.

Wild S, Roglic G, Green A, Sicree R, King H. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes care. 2004 May 1;27(5):1047-53.

Global report on diabetes. Available at: https://apps.who.int/iris/bitstream/handle/10665/204871/9789241565257_eng.pdf;sequence=1. Accessed 7 April 2016.

McLean E, Cogswell M, Egli I, Wojdyla D, de Benoist B. Worldwide prevalence of anaemia, WHO Vitamin and Mineral Nutrition Information System, 1993-2005. Public Health Nutr. 2008;12(04):444.

Astor BC, Muntner P, Levin A, Eustace JA, Coresh J. Association of kidney function with anemia: the Third National Health and Nutrition Examination Survey (1988-1994). Arch Int Med. 2002 Jun 24;162(12):1401-8.

Thomas M, MacIsaac R, Tsalamandris C, Power D, Jerums G. Unrecognized Anemia in Patients With Diabetes: A cross-sectional survey. Diabetes Care. 2003;26(4):1164-9.

Thomas M, MacIsaac R, Tsalamandris C, Molyneaux L, Goubina I, Fulcher G, et al. The burden of anaemia in type 2 diabetes and the role of nephropathy: a cross-sectional audit. Nephrol Dialysis Transplanta. 2004;19(7):1792-7.

American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes care. 2014 Jan 1;37(Supplement 1):S81-90.

Craig K, Williams J, Riley S, Smith H, Owens D, Worthing D, et al. Anemia and Diabetes in the Absence of Nephropathy. Diabetes Care. 2005;28(5):1118-23.

Kasper D, Fauci A, Hauser S, Longo D, Jameson J, Loscalzo J, et al. Appendix on Laboratory values of clinical importance, table 2 Clinical chemistry and immunology In: Harrison's principles of internal medicine. 19th ed. United states of America: Mc Graw Hill; 2015:2759.

Lin J, Bradley M. Azotemia and Urinary abnormalities. In: Kasper D, Fauci A, Hauser S, Longo D, Jameson J, Loscalzo J et al. Harrison's principles of internal medicine. 19th ed. United states of America: Mc Graw Hill; 2015:291.

Loutradis C, Skodra A, Georgianos P, Tolika P, Alexandrou D, Avdelidou A, et al. Diabetes mellitus increases the prevalence of anemia in patients with chronic kidney disease: A nested case-control study. World J Nephrol. 2016; 5(4): 358-366

McClellan WM, Jurkovitz C, Abramson J. The epidemiology, and control of anemia among pre-ESRD patients with chronic kidney disease. Eur J Clin Invest, 2005;35 Suppl 3:58-65.

Saran R, Li Y, Robinson B, Abbott KC, Agodoa LY, Ayanian J, et al. US Renal Data System 2015 Annual Data Report: Epidemiology of Kidney Disease in the United States. Am J Kidney Dis. 2016;67:A-A8.

Miller JA, Gravallese E, Bunn HF. Non-enzymatic glycosylation of erythrocyte membrane proteins. Relevance to diabetes. J Clin Invest. 1980;65:896-901.

Schnackenberg CG. Physiological and pathophysiological roles of oxygen radicals in the renal microvasculature. Am. J. Physiol. Regul Integr Comp Physiol. 2002;282:r335-r342.

Rathod GB, Parmar P, Rathod S, Parikh A. Prevalence of anemia in patients with Type 2 Diabetes Mellitus at Gandhinagar, Gujarat, India. IAIM. 2016;3(3):12-6.

Kojima K, Totsuka Y. Anemia due to reduced serum erythropoietin concentration in non-uremic diabetic patients. Diabetes Res Clini Pract. 1995 Mar 1;27(3):229-33.

Bae JC, Suh S, Jin SM, Kim SW, Hur KY, Kim JH, et al. Hemoglobin A1c values are affected by hemoglobin level and gender in non‐anemic Koreans. J Diab Investiga. 2014 Jan;5(1):60-5.